These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24341386)

  • 1. Triamidetriamine bearing macrobicyclic and macrotricyclic ligands: potential applications in the development of copper-64 radiopharmaceuticals.
    Tan KV; Pellegrini PA; Skelton BW; Hogan CF; Greguric I; Barnard PJ
    Inorg Chem; 2014 Jan; 53(1):468-77. PubMed ID: 24341386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrobicyclic cage amine ligands for copper radiopharmaceuticals: a single bivalent cage amine containing two Lys3-bombesin targeting peptides.
    Ma MT; Cooper MS; Paul RL; Shaw KP; Karas JA; Scanlon D; White JM; Blower PJ; Donnelly PS
    Inorg Chem; 2011 Jul; 50(14):6701-10. PubMed ID: 21667932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of a novel macrocyclic chelator with 3-hydroxy-4-pyrone chelating arms and its complexes with medicinally important metals.
    Yang CT; Sreerama SG; Hsieh WY; Liu S
    Inorg Chem; 2008 Apr; 47(7):2719-27. PubMed ID: 18281940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinuclear cobalt(II) and copper(II) complexes with a Py2N4S2 macrocyclic ligand.
    Núñez C; Bastida R; Lezama L; Macías A; Pérez-Lourido P; Valencia L
    Inorg Chem; 2011 Jun; 50(12):5596-604. PubMed ID: 21612192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals.
    Suzuki K; Shimmura N; Thipyapong K; Uehara T; Akizawa H; Arano Y
    Inorg Chem; 2008 Apr; 47(7):2593-600. PubMed ID: 18269240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper(I), silver(I), and palladium(II) complexes of a thiaoxamacrocycle displaying unusual topologies.
    Lee SY; Park S; Lee SS
    Inorg Chem; 2009 Dec; 48(23):11335-41. PubMed ID: 19902906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(II) complexes of a hexadentate mixed-donor N3S3 macrobicyclic cage: facile rearrangements and interconversions.
    Bell CA; Bernhardt PV; Gahan LR; Martínez M; Monteiro MJ; Rodríguez C; Sharrad CA
    Chemistry; 2010 Mar; 16(10):3166-75. PubMed ID: 20135649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and EPR studies on single-crystal and polycrystalline samples of copper(II) and cobalt(II) complexes with N2S2-based macrocyclic ligands.
    Tamayo A; Casabó J; Escriche L; González P; Lodeiro C; Rizzi AC; Brondino CD; Passeggi MC; Kivekäs R; Sillanpää R
    Inorg Chem; 2007 Jul; 46(14):5665-72. PubMed ID: 17564434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steric and hydrogen-bonding effects on the stability of copper complexes with small molecules.
    Wada A; Honda Y; Yamaguchi S; Nagatomo S; Kitagawa T; Jitsukawa K; Masuda H
    Inorg Chem; 2004 Sep; 43(18):5725-35. PubMed ID: 15332825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two macrocyclic pentaaza compounds containing pyridine evaluated as novel chelating agents in copper(II) and nickel(II) overload.
    Fernandes AS; Cabral MF; Costa J; Castro M; Delgado R; Drew MG; Félix V
    J Inorg Biochem; 2011 Mar; 105(3):410-9. PubMed ID: 21421127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural study of Ga(III), In(III), and Fe(III) complexes of triaza-macrocycle based ligands with N3S3 donor set.
    Notni J; Pohle K; Peters JA; Görls H; Platas-Iglesias C
    Inorg Chem; 2009 Apr; 48(7):3257-67. PubMed ID: 19281197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of nickel(II) and copper(II) complexes of a β-aminohydrazone ligand with pyridine-2-aldehyde: macrocyclization vs unprecedented pyrazole ring synthesis via C-C bond-forming reaction.
    Das O; Zangrando E; Paine TK
    Inorg Chem; 2011 Sep; 50(17):8012-9. PubMed ID: 21805958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and ligand exchange reactivity of a series of first row divalent metal 3-hydroxyflavonolate complexes.
    Grubel K; Rudzka K; Arif AM; Klotz KL; Halfen JA; Berreau LM
    Inorg Chem; 2010 Jan; 49(1):82-96. PubMed ID: 19954165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses, characterization, and dioxygen reactivities of Cu(I) complexes with cis,cis-1,3,5-triaminocyclohexane derivatives: a Cu(III)2O2 intermediate exhibiting higher C-H activation.
    Kajita Y; Arii H; Saito T; Saito Y; Nagatomo S; Kitagawa T; Funahashi Y; Ozawa T; Masuda H
    Inorg Chem; 2007 Apr; 46(8):3322-35. PubMed ID: 17371011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexes having the fac-[M(CO)3]+ core (M=Tc, Re) useful in radiopharmaceuticals: X-ray and NMR structural characterization and density functional calculations of species containing two sp3 N donors and one sp3 O donor.
    Lipowska M; Cini R; Tamasi G; Xu X; Taylor AT; Marzilli LG
    Inorg Chem; 2004 Nov; 43(24):7774-83. PubMed ID: 15554642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenolate and phenoxyl radical complexes of Cu(II) and Co(III), bearing a new redox active N,O-phenol-pyrazole ligand.
    Zats GM; Arora H; Lavi R; Yufit D; Benisvy L
    Dalton Trans; 2011 Nov; 40(41):10889-96. PubMed ID: 21743937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could redox-switched binding of a redox-active ligand to a copper(II) centre drive a conformational proton pump gate? A synthetic model study.
    He Z; Colbran SB; Craig DC
    Chemistry; 2003 Jan; 9(1):116-29. PubMed ID: 12506370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper complexes of thiosemicarbazone-pyridylhydrazine (THYNIC) hybrid ligands: a new versatile potential bifunctional chelator for copper radiopharmaceuticals.
    Cowley AR; Dilworth JR; Donnelly PS; White JM
    Inorg Chem; 2006 Jan; 45(2):496-8. PubMed ID: 16411680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper complexes of new benzodioxotetraaza macrocycles with potential applications in nuclear medicine.
    Antunes P; Delgado R; Drew MG; Félix V; Maecke H
    Inorg Chem; 2007 Apr; 46(8):3144-53. PubMed ID: 17378553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand influence over the formation of dinuclear [2+2] versus trinuclear [3+3] Cu(I) Schiff base macrocyclic complexes.
    Arbuse A; Mandal S; Maji S; Martínez MA; Fontrodona X; Utz D; Heinemann FW; Kisslinger S; Schindler S; Sala X; Llobet A
    Inorg Chem; 2011 Aug; 50(15):6878-89. PubMed ID: 21732585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.